Pact With NCI Expands Veterans' Access to Trials

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 2
Volume 6
Issue 2

BETHESDA, Md--In a move designed to increase the pool of patients available for clinical trials, the National Cancer Institute has forged an agreement with the Department of Veterans Affairs that will increase the ability of veterans to enroll in phase I, II, and III studies.

BETHESDA, Md--In a move designed to increase the pool of patients availablefor clinical trials, the National Cancer Institute has forged an agreementwith the Department of Veterans Affairs that will increase the abilityof veterans to enroll in phase I, II, and III studies.

Under the agreement, the VA will provide medical coverage for eligibleveterans who participate in NCI-supported studies at non-VA facilities.The pact also envisions that more NCI studies will be conducted in VA hospitalsand clinics.

"Developing an expanded pool of VA cancer researchers will strengthenour clinical research program across the board," said Robert Wittes,MD, director of NCI's Division of Cancer Treatment, Diagnosis, and Centers.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
A paucity of prospective, well-vetted data to guide therapy in patients with rare lymphomas may result in a reliance on expert consensus guidelines.
1 expert in this video
1 expert in this video
1 expert in this video
Testing a patient’s genetics may influence decisions such as using longer courses of radiotherapy, says Rachit Kumar, MD.
Related Content